BACKGROUND: The henipaviruses, Hendra virus (HeV) and Nipah virus (NiV), are capable of causing severe and often lethal respiratory and/or neurologic disease in animals and humans. Given the sporadic nature of henipavirus outbreaks, licensure of vaccines and therapeutics for human use will likely require demonstration of efficacy in animal models that faithfully reproduce the human condition. Currently, the African green monkey (AGM) best mimics human henipavirus-induced disease. METHODS: The pathogenic potential of HeV and both strains of NiV (Malaysia, Bangladesh) was assessed in cynomolgus monkeys and compared with henipavirus-infected historical control AGMs. Multiplex gene and protein expression assays were used to compare host responses. RESULTS: In contrast to AGMs, in which henipaviruses cause severe and usually lethal disease, HeV and NiVs caused only mild or asymptomatic infections in macaques. All henipaviruses replicated in macaques with similar kinetics as in AGMs. Infection in macaques was associated with activation and predicted recruitment of cytotoxic CD8+ T cells, Th1 cells, IgM+ B cells, and plasma cells. Conversely, fatal outcome in AGMs was associated with aberrant innate immune signaling, complement dysregulation, Th2 skewing, and increased secretion of MCP-1. CONCLUSION: The restriction factors identified in macaques can be harnessed for development of effective countermeasures against henipavirus disease.
BACKGROUND: The henipaviruses, Hendra virus (HeV) and Nipah virus (NiV), are capable of causing severe and often lethal respiratory and/or neurologic disease in animals and humans. Given the sporadic nature of henipavirus outbreaks, licensure of vaccines and therapeutics for human use will likely require demonstration of efficacy in animal models that faithfully reproduce the human condition. Currently, the African green monkey (AGM) best mimics human henipavirus-induced disease. METHODS: The pathogenic potential of HeV and both strains of NiV (Malaysia, Bangladesh) was assessed in cynomolgus monkeys and compared with henipavirus-infected historical control AGMs. Multiplex gene and protein expression assays were used to compare host responses. RESULTS: In contrast to AGMs, in which henipaviruses cause severe and usually lethal disease, HeV and NiVs caused only mild or asymptomatic infections in macaques. All henipaviruses replicated in macaques with similar kinetics as in AGMs. Infection in macaques was associated with activation and predicted recruitment of cytotoxic CD8+ T cells, Th1 cells, IgM+ B cells, and plasma cells. Conversely, fatal outcome in AGMs was associated with aberrant innate immune signaling, complement dysregulation, Th2 skewing, and increased secretion of MCP-1. CONCLUSION: The restriction factors identified in macaques can be harnessed for development of effective countermeasures against henipavirus disease.
Authors: Xiao-Song He; Monia Draghi; Kutubuddin Mahmood; Tyson H Holmes; George W Kemble; Cornelia L Dekker; Ann M Arvin; Peter Parham; Harry B Greenberg Journal: J Clin Invest Date: 2004-12 Impact factor: 14.808
Authors: Birgit Nikolay; Henrik Salje; M Jahangir Hossain; A K M Dawlat Khan; Hossain M S Sazzad; Mahmudur Rahman; Peter Daszak; Ute Ströher; Juliet R C Pulliam; A Marm Kilpatrick; Stuart T Nichol; John D Klena; Sharmin Sultana; Sayma Afroj; Stephen P Luby; Simon Cauchemez; Emily S Gurley Journal: N Engl J Med Date: 2019-05-09 Impact factor: 91.245
Authors: Emily S Gurley; Joel M Montgomery; M Jahangir Hossain; Michael Bell; Abul Kalam Azad; Mohammed Rafiqul Islam; Mohammed Abdur Rahim Molla; Darin S Carroll; Thomas G Ksiazek; Paul A Rota; Luis Lowe; James A Comer; Pierre Rollin; Markus Czub; Allen Grolla; Heinz Feldmann; Stephen P Luby; Jennifer L Woodward; Robert F Breiman Journal: Emerg Infect Dis Date: 2007-07 Impact factor: 6.883
Authors: Yu Cong; Margaret R Lentz; Abigail Lara; Isis Alexander; Christopher Bartos; J Kyle Bohannon; Dima Hammoud; Louis Huzella; Peter B Jahrling; Krisztina Janosko; Catherine Jett; Erin Kollins; Matthew Lackemeyer; Daniel Mollura; Dan Ragland; Oscar Rojas; Jeffrey Solomon; Ziyue Xu; Vincent Munster; Michael R Holbrook Journal: PLoS Negl Trop Dis Date: 2017-04-07
Authors: Joan B Geisbert; Viktoriya Borisevich; Abhishek N Prasad; Krystle N Agans; Stephanie L Foster; Daniel J Deer; Robert W Cross; Chad E Mire; Thomas W Geisbert; Karla A Fenton Journal: J Infect Dis Date: 2020-05-11 Impact factor: 5.226
Authors: Yvonne Jing Mei Liew; Puteri Ainaa S Ibrahim; Hui Ming Ong; Chee Ning Chong; Chong Tin Tan; Jie Ping Schee; Raúl Gómez Román; Neil George Cherian; Won Fen Wong; Li-Yen Chang Journal: Microorganisms Date: 2022-06-06
Authors: Stephanie L Foster; Courtney Woolsey; Viktoriya Borisevich; Krystle N Agans; Abhishek N Prasad; Daniel J Deer; Joan B Geisbert; Natalie S Dobias; Karla A Fenton; Robert W Cross; Thomas W Geisbert Journal: Proc Natl Acad Sci U S A Date: 2022-03-14 Impact factor: 11.205
Authors: Courtney Woolsey; Viktoriya Borisevich; Krystle N Agans; Karla A Fenton; Robert W Cross; Thomas W Geisbert Journal: mBio Date: 2021-08-10 Impact factor: 7.867